Retatrutide UK

Price range: £165.00 through £310.00

Retatrutide, also known as LY3437943, is an investigational triple hormone-receptor agonist being studied for its potential effects on metabolic health. It targets GIP, GLP-1 and glucagon receptors.

Retatrutide has not been authorised for general public use in the UK. This page provides factual information about its clinical research, investigational status and current regulatory position.

For official information, consult the MHRA and the Eli Lilly research pipeline.

SKU: N/A Category: Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,